After a temporary hiatus, the World Health Organization announced Wednesday that it will resume a clinical trial that is looking into the effectiveness of using anti-malaria drug hydroxychloroquine as a treatment for COVID-19.
After a temporary hiatus, the World Health Organization announced Wednesday that it will resume a clinical trial that is looking into the effectiveness of using anti-malaria drug hydroxychloroquine as a treatment for COVID-19.